Modeling Retinitis Pigmentosa with Patient-Derived iPSCs.
Adv Exp Med Biol
; 1415: 555-563, 2023.
Article
em En
| MEDLINE
| ID: mdl-37440086
ABSTRACT
Retinitis pigmentosa (RP) causes blindness in 1 out of 3000-4000 individuals worldwide. Understanding the disease mechanism underlying the death of photoreceptors in RP patient is crucial for the discovery and development of therapies to prevent and stop the progression of retinal degeneration. Despite having provided valuable insight into RP pathology, several shortcomings of animal models warrant the need for a better modeling system. This review discusses the current use of patient-derived induced pluripotent stem cells (iPSCs) to model RP and its advantages over animal models. Further improvement to enhance the representativeness of iPSC RP models is also discussed.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Degeneração Retiniana
/
Retinose Pigmentar
/
Células-Tronco Pluripotentes Induzidas
Limite:
Animals
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article